Equine Product ‘Surpass’ Purchased by Boehringer Ingelheim
Boehringer Ingelheim Vetmedica Inc. (BIVI) recently announced it has purchased the product Surpass (1% diclofenac sodium) from Idexx Laboratories Inc. Surpass will be marketed through the existing animal health distribution channels and
- Topics: Article, Equine Welfare Legislation
Share
ADVERTISEMENT
Create a free account with TheHorse.com to view this content.
TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.
Start your free account today!
Already have an account?
and continue reading.
Share
Related Articles
Stay on top of the most recent Horse Health news with
